{"transactions":[{"id":4636999,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-10-07T20:12:07.000Z","date":"2026-10-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17948,"price":5,"value":89740.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares tendered to the Issuer pursuant to the Issuer's tender offer. The Issuer took up and accepted the common shares for payment on October 1, 2026."}],"balance_after":14328,"source":{"system":"sec-edgar","filing":"0001447028-26-000061","document":"wk-form4_1791403925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702826000061/wk-form4_1791403925.xml","form_type":"4"}},{"id":4625856,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-24T00:31:01.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":78800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing a right to purchase a total of 78,800 shares, was fully vested and exercisable as of the June 8, 2026 grant date."}],"balance_after":0,"derivative":{"exercise_price":4.24,"exercise_date":"2026-06-08","expiration_date":"2036-06-08","underlying":"Common Shares","underlying_shares":78800},"source":{"system":"sec-edgar","filing":"0001447028-26-000050","document":"wk-form4_1790209858.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702826000050/wk-form4_1790209858.xml","form_type":"4"}},{"id":4625855,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-24T00:31:01.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":52533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, representing a right to purchase a total of 157,600 shares, vests over a three-year period, with 1/3rd of the total shares subject to the option vesting at each of the 1st, 2nd and 3rd anniversaries of the March 18, 2025 grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":105067,"derivative":{"exercise_price":3.2,"expiration_date":"2035-03-18","underlying":"Common Shares","underlying_shares":52533},"source":{"system":"sec-edgar","filing":"0001447028-26-000050","document":"wk-form4_1790209858.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702826000050/wk-form4_1790209858.xml","form_type":"4"}},{"id":4625854,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-24T00:31:01.000Z","date":"2026-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":99057,"price":5.07,"value":502218.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person exercised options on September 18, 2026. The Issuer withheld an aggregate of 99,057 shares otherwise issuable upon the exercises to satisfy the aggregate exercise prices."}],"balance_after":32276,"source":{"system":"sec-edgar","filing":"0001447028-26-000050","document":"wk-form4_1790209858.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702826000050/wk-form4_1790209858.xml","form_type":"4"}},{"id":4625853,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-24T00:31:01.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":78800,"price":4.24,"value":334112.0,"ownership":{"direct":true},"balance_after":131333,"source":{"system":"sec-edgar","filing":"0001447028-26-000050","document":"wk-form4_1790209858.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702826000050/wk-form4_1790209858.xml","form_type":"4"}},{"id":4625852,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-24T00:31:01.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":52533,"price":3.2,"value":168105.6,"ownership":{"direct":true},"balance_after":52533,"source":{"system":"sec-edgar","filing":"0001447028-26-000050","document":"wk-form4_1790209858.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702826000050/wk-form4_1790209858.xml","form_type":"4"}},{"id":743030,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T20:05:24.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":78800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":78800,"derivative":{"exercise_price":4.24,"exercise_date":"2026-06-08","expiration_date":"2036-06-08","underlying":"Common Shares","underlying_shares":78800},"source":{"system":"sec-edgar","filing":"0001447028-26-000039","document":"wk-form4_1781121921.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702826000039/wk-form4_1781121921.xml","form_type":"4"}},{"id":1195596,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-20T20:10:16.000Z","date":"2025-03-18","kind":"grant","planned":false,"acquired":true,"shares":157600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests over a three-year period, with 1/3rd of the total shares subject to the option vesting at each of the 1st, 2nd, and 3rd anniversaries of the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":157600,"derivative":{"exercise_price":3.2,"expiration_date":"2035-03-18","underlying":"Common Shares","underlying_shares":157600},"source":{"system":"sec-edgar","filing":"0001447028-25-000075","document":"wk-form4_1742501408.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702825000075/wk-form4_1742501408.xml","form_type":"4"}},{"id":1986401,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-01T00:06:09.000Z","date":"2023-02-25","kind":"grant","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 25, 2023."}],"balance_after":135000,"derivative":{"exercise_price":1.78,"expiration_date":"2033-02-24","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0000899243-23-006475","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1310845/000089924323006475/doc4.xml","form_type":"4"}},{"id":2106708,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2022-11-22T21:05:13.000Z","date":"2022-11-21","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option has fully vested and is currently exercisable."}],"balance_after":75651,"derivative":{"exercise_price":1.07,"expiration_date":"2022-11-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-22-036697","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1310845/000089924322036697/doc4.xml","form_type":"4"}},{"id":2106707,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-11-22T21:05:13.000Z","date":"2022-11-21","kind":"exercise","acquired":true,"shares":10000,"price":1.07,"value":10700.0,"ownership":{"direct":true},"balance_after":108191,"source":{"system":"sec-edgar","filing":"0000899243-22-036697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1310845/000089924322036697/doc4.xml","form_type":"4"}},{"id":2160041,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2022-09-13T20:10:13.000Z","date":"2022-09-12","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option has fully vested and is currently exercisable."}],"balance_after":85651,"derivative":{"exercise_price":1.07,"expiration_date":"2022-11-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-22-030911","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1310845/000089924322030911/doc4.xml","form_type":"4"}},{"id":2160040,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-09-13T20:10:13.000Z","date":"2022-09-12","kind":"exercise","acquired":true,"shares":10000,"price":1.07,"value":10700.0,"ownership":{"direct":true},"balance_after":98191,"source":{"system":"sec-edgar","filing":"0000899243-22-030911","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1310845/000089924322030911/doc4.xml","form_type":"4"}},{"id":2359903,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-02T21:06:14.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 28, 2022."}],"balance_after":75000,"derivative":{"exercise_price":2.24,"expiration_date":"2032-02-27","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-22-008585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1310845/000089924322008585/doc4.xml","form_type":"4"}},{"id":2463633,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2021-12-20T23:30:10.000Z","date":"2021-12-17","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option has fully vested and is currently exercisable."}],"balance_after":95651,"derivative":{"exercise_price":1.07,"expiration_date":"2022-11-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-21-049011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1310845/000089924321049011/doc4.xml","form_type":"4"}},{"id":2463632,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-12-20T23:30:10.000Z","date":"2021-12-17","kind":"exercise","acquired":true,"shares":20000,"price":1.07,"value":21400.0,"ownership":{"direct":true},"balance_after":88191,"source":{"system":"sec-edgar","filing":"0000899243-21-049011","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1310845/000089924321049011/doc4.xml","form_type":"4"}},{"id":2891943,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-28T21:05:13.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four year period commencing January 26, 2021."}],"balance_after":75000,"derivative":{"exercise_price":11.99,"expiration_date":"2031-01-25","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-21-003611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1310845/000089924321003611/doc4.xml","form_type":"4"}},{"id":3290882,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-04T23:00:32.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":74435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four year period commencing January 31, 2020."}],"balance_after":74435,"derivative":{"exercise_price":14.84,"expiration_date":"2030-01-30","underlying":"Common Stock","underlying_shares":74435},"source":{"system":"sec-edgar","filing":"0000899243-20-002866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1310845/000089924320002866/doc4.xml","form_type":"4"}},{"id":3374175,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Series C Preferred Stock","published_at":"2019-11-12T21:15:24.000Z","date":"2019-11-12","kind":"exercise","acquired":false,"shares":6774,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.197763-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.197763-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.197763-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.197763-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1339},"source":{"system":"sec-edgar","filing":"0000899243-19-027114","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1310845/000089924319027114/doc4.xml","form_type":"4"}},{"id":3374174,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Series B Preferred Stock","published_at":"2019-11-12T21:15:24.000Z","date":"2019-11-12","kind":"exercise","acquired":false,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.197763-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.197763-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.197763-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.197763-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":395},"source":{"system":"sec-edgar","filing":"0000899243-19-027114","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1310845/000089924319027114/doc4.xml","form_type":"4"}},{"id":3374173,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Series A Preferred Stock","published_at":"2019-11-12T21:15:24.000Z","date":"2019-11-12","kind":"exercise","acquired":false,"shares":68907,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.197763-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.197763-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.197763-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.197763-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":13627},"source":{"system":"sec-edgar","filing":"0000899243-19-027114","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1310845/000089924319027114/doc4.xml","form_type":"4"}},{"id":3374172,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":39643,"kind":"person","name":"Beardsley Robert A","position":1,"cik":"0001310845","reported_name":"Beardsley Robert A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-11-12T21:15:24.000Z","date":"2019-11-12","kind":"exercise","acquired":true,"shares":15361,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.197763-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.197763-for-one basis."}],"balance_after":68191,"source":{"system":"sec-edgar","filing":"0000899243-19-027114","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1310845/000089924319027114/doc4.xml","form_type":"4"}}]}